Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 2
1983 1
1985 1
1986 4
1987 10
1988 10
1989 9
1990 16
1991 16
1992 14
1993 22
1994 23
1995 22
1996 37
1997 27
1998 29
1999 34
2000 44
2001 31
2002 37
2003 41
2004 44
2005 41
2006 33
2007 34
2008 33
2009 37
2010 29
2011 24
2012 34
2013 32
2014 30
2015 18
2016 20
2017 14
2018 16
2019 20
2020 19
2021 17
Text availability
Article attribute
Article type
Publication date

Search Results

882 results
Results by year
Filters applied: . Clear all
Page 1
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. Eisenhauer EA, et al. Among authors: verweij j. Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026. Eur J Cancer. 2009. PMID: 19097774
Innovation in oncology clinical trial design.
Verweij J, Hendriks HR, Zwierzina H; Cancer Drug Development Forum. Verweij J, et al. Cancer Treat Rev. 2019 Mar;74:15-20. doi: 10.1016/j.ctrv.2019.01.001. Epub 2019 Jan 4. Cancer Treat Rev. 2019. PMID: 30665053 Review.
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, Kerst JM, Sufliarsky J, Whelan J, Hohenberger P, Krarup-Hansen A, Alcindor T, Marreaud S, Litière S, Hermans C, Fisher C, Hogendoorn PC, dei Tos AP, van der Graaf WT; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Judson I, et al. Among authors: verweij j. Lancet Oncol. 2014 Apr;15(4):415-23. doi: 10.1016/S1470-2045(14)70063-4. Epub 2014 Mar 5. Lancet Oncol. 2014. PMID: 24618336 Clinical Trial.
COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study.
Sikkema RS, Pas SD, Nieuwenhuijse DF, O'Toole Á, Verweij J, van der Linden A, Chestakova I, Schapendonk C, Pronk M, Lexmond P, Bestebroer T, Overmars RJ, van Nieuwkoop S, van den Bijllaardt W, Bentvelsen RG, van Rijen MML, Buiting AGM, van Oudheusden AJG, Diederen BM, Bergmans AMC, van der Eijk A, Molenkamp R, Rambaut A, Timen A, Kluytmans JAJW, Oude Munnink BB, Kluytmans van den Bergh MFQ, Koopmans MPG. Sikkema RS, et al. Among authors: verweij j. Lancet Infect Dis. 2020 Nov;20(11):1273-1280. doi: 10.1016/S1473-3099(20)30527-2. Epub 2020 Jul 2. Lancet Infect Dis. 2020. PMID: 32622380 Free PMC article.
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. Demetri GD, et al. Among authors: verweij j. Lancet. 2006 Oct 14;368(9544):1329-38. doi: 10.1016/S0140-6736(06)69446-4. Lancet. 2006. PMID: 17046465 Clinical Trial.
Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic.
Kluytmans-van den Bergh MFQ, Buiting AGM, Pas SD, Bentvelsen RG, van den Bijllaardt W, van Oudheusden AJG, van Rijen MML, Verweij JJ, Koopmans MPG, Kluytmans JAJW. Kluytmans-van den Bergh MFQ, et al. Among authors: verweij jj. JAMA Netw Open. 2020 May 1;3(5):e209673. doi: 10.1001/jamanetworkopen.2020.9673. JAMA Netw Open. 2020. PMID: 32437576 Free PMC article.
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, Ghadjar P, Hohenberger P, Angele M, Salat C, Vujaskovic Z, Daugaard S, Mella O, Mansmann U, Dürr HR, Knösel T, Abdel-Rahman S, Schmidt M, Hiddemann W, Jauch KW, Belka C, Gronchi A; European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology. Issels RD, et al. Among authors: verweij j. JAMA Oncol. 2018 Apr 1;4(4):483-492. doi: 10.1001/jamaoncol.2017.4996. JAMA Oncol. 2018. PMID: 29450452 Free PMC article. Clinical Trial.
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P; EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. Woll PJ, et al. Among authors: verweij j. Lancet Oncol. 2012 Oct;13(10):1045-54. doi: 10.1016/S1470-2045(12)70346-7. Epub 2012 Sep 4. Lancet Oncol. 2012. PMID: 22954508 Clinical Trial.
Gynaecological sarcomas.
Sleijfer S, Seynaeve C, Verweij J. Sleijfer S, et al. Among authors: verweij j. Curr Opin Oncol. 2007 Sep;19(5):492-6. doi: 10.1097/CCO.0b013e3282748eaa. Curr Opin Oncol. 2007. PMID: 17762577 Review.
882 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page